Fukase, Y., Sato, A., Tomata, Y., Ochida, A., Kono, M., Yonemori, K., … Yamamoto, S. (2017). Identification of novel quinazolinedione derivatives as RORγt inverse agonist. Bioorganic & Medicinal Chemistry. https://doi.org/10.1016/j.bmc.2017.12.039 (Original work published 2017)

Amano, Y., Yamakawa, H., Yonemori, K., Shimada, M., & Tozawa, R. (2017). Farnesoid X receptor antagonist exacerbates dyslipidemia in mice. Pharmacological Reports : PR, 70(1), 172-177. https://doi.org/10.1016/j.pharep.2017.07.010 (Original work published 2017)

Fujiwara, Y., Kenmotsu, H., Yamamoto, N., Shimizu, T., Yonemori, K., Ocampo, C., … Murakami, H. (2021). Phase 1 study of telisotuzumab vedotin in Japanese patients with advanced solid tumors. Cancer Medicine, 10(7), 2350-2358. https://doi.org/10.1002/cam4.3815